Template:Oral hypoglycemics and insulin analogs: Difference between revisions
Content deleted Content added
Tirzepatide approved |
Add #WHO-EM marks |
||
| Line 16: | Line 16: | ||
| group2 = ''short-acting'' |
| group2 = ''short-acting'' |
||
| list2 = |
| list2 = |
||
*[[Regular insulin]] |
*[[Regular insulin]]<sup>#</sup> |
||
| group3 = ''long-acting'' |
| group3 = ''long-acting'' |
||
| Line 28: | Line 28: | ||
| group4 = ''ultra-long-acting'' |
| group4 = ''ultra-long-acting'' |
||
| list4 = |
| list4 = |
||
*[[Insulin degludec]] ([[Insulin degludec/insulin aspart|+insulin aspart]], [[Insulin degludec/liraglutide|+liraglutide]]) |
*[[Insulin degludec]]<sup>#</sup> ([[Insulin degludec/insulin aspart|+insulin aspart]], [[Insulin degludec/liraglutide|+liraglutide]]) |
||
| group5 = ''[[Inhalable insulin|inhalable]]'' |
| group5 = ''[[Inhalable insulin|inhalable]]'' |
||
Revision as of 22:58, 1 March 2023
This template's initial visibility currently defaults to autocollapse, meaning that if there is another collapsible item on the page (a navbox, sidebar, or table with the collapsible attribute), it is hidden apart from its title bar; if not, it is fully visible.
To change this template's initial visibility, the |state= parameter may be used:
{{Oral hypoglycemics and insulin analogs|state=collapsed}}will show the template collapsed, i.e. hidden apart from its title bar.{{Oral hypoglycemics and insulin analogs|state=expanded}}will show the template expanded, i.e. fully visible.